Cargando…
Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations
BACKGROUND: Phelan-McDermid syndrome (PMS) is a neurodevelopmental disorder characterized by psychiatric and neurological features. Most reported cases are caused by 22q13.3 deletions, leading to SHANK3 haploinsufficiency, but also usually encompassing many other genes. While the number of point mut...
Autores principales: | De Rubeis, Silvia, Siper, Paige M., Durkin, Allison, Weissman, Jordana, Muratet, François, Halpern, Danielle, Trelles, Maria del Pilar, Frank, Yitzchak, Lozano, Reymundo, Wang, A. Ting, Holder, J. Lloyd, Betancur, Catalina, Buxbaum, Joseph D., Kolevzon, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921983/ https://www.ncbi.nlm.nih.gov/pubmed/29719671 http://dx.doi.org/10.1186/s13229-018-0205-9 |
Ejemplares similares
-
A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome
por: Fastman, J., et al.
Publicado: (2021) -
Clinical trial of insulin-like growth factor-1 in Phelan-McDermid syndrome
por: Kolevzon, A., et al.
Publicado: (2022) -
Psychiatric illness and regression in individuals with Phelan-McDermid syndrome
por: Kohlenberg, Teresa M., et al.
Publicado: (2020) -
Strong evidence for genotype–phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortium
por: Levy, Tess, et al.
Publicado: (2021) -
A proof-of-concept study of growth hormone in children with Phelan–McDermid syndrome
por: Sethuram, S., et al.
Publicado: (2022)